Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Comin Colet

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
Journal of Clinical Medicine|June 10, 2022
Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?Andrew Sindone, Wolfram Doehner, Nicolas Manito, et al.
Heart Failure Reviews|July 5, 2015
A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptomsFarzin Beygui, Manuel Anguita, Ulrich Tebbe, et al.
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centreElena Collado, Daniele Luiso, Albert Ariza-Solé, et al.
European Journal of Heart Failure|March 21, 2024
Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER dataJason A Davis, David Booth, Phil McEwan, et al.
European Journal of Heart Failure|June 22, 2023
The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trialDavid Booth, Jason A Davis, Phil McEwan, et al.
American Journal of Hematology|October 26, 2016
Management of anemia in patients with congestive heart failureLawrence Tim Goodnough, Josep Comin-Colet, Santiago Leal-Noval, et al.
Heart Rhythm|July 3, 2024
Variations in threshold values for border zone and dense scar produce significant changes in scar parameters obtained by ADAS-3DValentina Faga, Paolo D Dallaglio, Eduard Claver, et al.
International Journal of Cardiology|July 23, 2013
Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysisFlorian S Gutzwiller, Alena M Pfeil, Josep Comin-Colet, et al.
European Journal of Cardiovascular Nursing|February 14, 2019
Efficacy of a nurse-led lipid-lowering secondary prevention intervention in patients hospitalized for ischemic heart disease: A pilot randomized controlled trialSonia Ruiz-Bustillo, Consol Ivern, Neus Badosa, et al.
European Journal of Heart Failure|March 21, 2013
High-intensity vs. sham inspiratory muscle training in patients with chronic heart failure: a prospective randomized trialEster Marco, Alba L Ramírez-Sarmiento, Ana Coloma, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Journal of Clinical Medicine|June 10, 2022
Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?Andrew Sindone, Wolfram Doehner, Nicolas Manito, et al.
Heart Failure Reviews|July 5, 2015
A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptomsFarzin Beygui, Manuel Anguita, Ulrich Tebbe, et al.
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centreElena Collado, Daniele Luiso, Albert Ariza-Solé, et al.
European Journal of Heart Failure|March 21, 2024
Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER dataJason A Davis, David Booth, Phil McEwan, et al.
European Journal of Heart Failure|June 22, 2023
The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trialDavid Booth, Jason A Davis, Phil McEwan, et al.
American Journal of Hematology|October 26, 2016
Management of anemia in patients with congestive heart failureLawrence Tim Goodnough, Josep Comin-Colet, Santiago Leal-Noval, et al.
Heart Rhythm|July 3, 2024
Variations in threshold values for border zone and dense scar produce significant changes in scar parameters obtained by ADAS-3DValentina Faga, Paolo D Dallaglio, Eduard Claver, et al.
International Journal of Cardiology|July 23, 2013
Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysisFlorian S Gutzwiller, Alena M Pfeil, Josep Comin-Colet, et al.
European Journal of Cardiovascular Nursing|February 14, 2019
Efficacy of a nurse-led lipid-lowering secondary prevention intervention in patients hospitalized for ischemic heart disease: A pilot randomized controlled trialSonia Ruiz-Bustillo, Consol Ivern, Neus Badosa, et al.
European Journal of Heart Failure|March 21, 2013
High-intensity vs. sham inspiratory muscle training in patients with chronic heart failure: a prospective randomized trialEster Marco, Alba L Ramírez-Sarmiento, Ana Coloma, et al.
Pageof 16